Sequence Bio

[On Demand]
Sequence Bio is a Newfoundland and Labrador-based biotechnology company accelerating novel target identification with custom discovery and validation cohorts powered by the province’s founder population.

By combining founder population multi-omics with medical and other health information, Sequence Bio’s target discovery platform is purpose-built to produce bespoke cohorts, supported by custom phenotyping, for more efficient and effective discovery and validation of novel drug targets.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Newfoundland And Labrador
Company HQ Country:
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Target discovery platform
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Chief Strategy Officer
Sequence Bio